Skin conditions in epileptics
dc.contributor.author | Swart E. | |
dc.contributor.author | De Lochner V.J. | |
dc.date.accessioned | 2011-05-15T16:16:04Z | |
dc.date.available | 2011-05-15T16:16:04Z | |
dc.date.issued | 1992 | |
dc.description.abstract | The prevalence of skin and mucous membrane conditions occurring in 173 epileptics between the ages of 6 and 19 years was compared with that of an age-matched group of 211 non-epileptics. The most frequently used anticonvulsants, singly or in combination, were carbamazepine in 54.9%, phenytoin in 47.8%, barbiturates in 36.6% and ethosuximide in 11.2% of epileptics. The most frequent combination was phenytoin and carbamazepine in 14% of the males and 18.4% of the females. An increased prevalence of acne was found in epileptic females; 80.3% compared to 30.2% in non-epileptic females. Hirsutism vas found in 43.9% of the female epileptics compared to 7.5% of the non-epileptic females. Of interest was the finding of punctate and linear scars on the dorsum of the hands of 27.7% epileptics compared to 3.8% non-epileptics. Both ephilides and naevocellular naevi occurred in 12.7% of the epileptics compared to 29.4% and 52.1% respectively of the non-epileptics. Leukonychia was also found more frequently in epileptics than in non-epileptics; 52% and 28.9% respectively. | |
dc.description.version | Article | |
dc.identifier.citation | Clinical and Experimental Dermatology | |
dc.identifier.citation | 17 | |
dc.identifier.citation | 3 | |
dc.identifier.issn | 03076938 | |
dc.identifier.other | 10.1111/j.1365-2230.1992.tb00197.x | |
dc.identifier.uri | http://hdl.handle.net/10019.1/13619 | |
dc.subject | anticonvulsive agent | |
dc.subject | barbituric acid derivative | |
dc.subject | carbamazepine | |
dc.subject | ethosuximide | |
dc.subject | phenytoin | |
dc.subject | adolescent | |
dc.subject | adult | |
dc.subject | article | |
dc.subject | child | |
dc.subject | epilepsy | |
dc.subject | female | |
dc.subject | human | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | oral drug administration | |
dc.subject | priority journal | |
dc.subject | skin disease | |
dc.subject | Adolescent | |
dc.subject | Adult | |
dc.subject | Anticonvulsants | |
dc.subject | Child | |
dc.subject | Drug Eruptions | |
dc.subject | Epilepsy, Tonic-Clonic | |
dc.subject | Female | |
dc.subject | Human | |
dc.subject | Male | |
dc.subject | Skin Diseases | |
dc.title | Skin conditions in epileptics | |
dc.type | Article |